Caffeine discontinuation at a greater post menstrual age is associated with better kidney outcomes at 24 months corrected age
Saturday, April 23, 2022
3:30 PM – 3:45 PM US MT
Location: Convention Center: Mile High Ballroom 3AB
CE: Enduring CME: 0.25
Publication Number: 1635.1
Matthew W. Harer, University of Wisconsin, Middleton, WI, United States; Russell L. Griffin, UNIVERSITY OF ALABAMA AT BIRMINGHAM, Birmingham, AL, United States; Cara Slagle, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Meredith P. Schuh, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Mamta Fuloria, The Children's Hospital at Montefiore, Bronx, NY, United States; Mina Hanna, University of Kentucky College of Medicine, Lexington, KY, United States; Robert Woroniecki, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States; Ronnie Guillet, Golisano Children's Hospital at The University of Rochester Medical Center, Rochester, NY, United States; David Askenazi, UAB, Birmingham, AL, United States; Jennifer R. Charlton, University of Virginia School of Medicine, Charlottesville, VA, United States
Presenting Author(s)
Matthew W. Harer, MD (he/him/his)
Associate Professor of Pediatrics University of Wisconsin School of Medicine and Public Health Waunakee, WI, United States
Participants should be aware of the following financial/non-financial relationships:
Matthew W. Harer, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Russell L. Griffin, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Cara Slagle, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Meredith P. Schuh, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mamta Fuloria, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mina Hanna, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Robert Woroniecki, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ronnie Guillet, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
David Askenazi, MD, MSPH: ● Baxter (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Bioporto (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Medtronic (Products/Services: Consultant). ● Nuwellis (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant). ● Seastar (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant).
Jennifer R. Charlton, MD, MSc: I do not have any relevant financial / non-financial relationships with any proprietary interests.
